Naaman Mehta, Sarah S. Lee, & Ghadir Salame. (2023). A case of pembrolizumab and lenvatinib as an alterntive therapy for leiomyosarcoma. Elsevier.
Chicago Style (17th ed.) CitationNaaman Mehta, Sarah S. Lee, and Ghadir Salame. A Case of Pembrolizumab and Lenvatinib as an Alterntive Therapy for Leiomyosarcoma. Elsevier, 2023.
MLA (9th ed.) CitationNaaman Mehta, et al. A Case of Pembrolizumab and Lenvatinib as an Alterntive Therapy for Leiomyosarcoma. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.